Metacrine investor relations
WebOur Board of Directors consists of 7 members and will be elected annually on a staggered basis. Semiramis Paliou Director and Chairperson of the Board Ioannis Zafirakis Director, President, Interim Chief Financial Officer and Secretary Eleftherios Papatrifon Director Styliani Alexandra Sougioultzoglou Director Grigorios-Filippos Psaltis Director Web16 sep. 2024 · See Metacrine's detailed income statement and balance sheet. Find out their revenue, expenses and profit or loss over the last fiscal year. Metacrine Stock Price, …
Metacrine investor relations
Did you know?
WebAmended and Restated 2015 Equity Incentive Plan . 2024 Equity Incentive Plan . 2024 Employee Stock Purchase Plan (Full titles of the plans) Preston Klassen, M.D. President and Chi Web17 jun. 2024 · Investor & Media Contact Steve Kunszabo Metacrine, Inc. +1 (858) 369-7892 [email protected] © GlobeNewswire 2024 All news about METACRINE, INC. More news Analyst Recommendations on METACRINE, INC. More recommendations Financials (USD) Technical analysis trends METACRINE, INC.
Webwww.metacrine.com http://browsbyliah.com/p0xy7/venrock-portfolio
WebMETACRINE, INC. : Financial news and information Stock METACRINE, INC. Nasdaq: MTCR Nasdaq Web13 apr. 2024 · Der Höchststand, in den letzten 52 Wochen, der Metacrine Aktie lag bei 0,580 USD (am 03.04.23).Laut aktuellem Kurs ist die Metacrine Aktie -3,45 % vom 52 …
WebMetacrine, Inc. 4225 Executive Square, Suite 600 San Diego, CA 92037
Web6 apr. 2024 · The company can be reached via phone at 858-369-7800 or via email at [email protected]. This page (NASDAQ:MTCR) was last updated on … gainsborough physiotherapy clinicWeb10 uur geleden · The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor... black bart\u0027s steakhousehttp://oceanpal.com/ gainsborough picturesWebEquillium grants Ono an option to purchase rights to itolizumab Equillium to receive an upfront payment of approximately $26.0M (¥3.5B); eligible to receive up to approximately $138.5M (¥18.7B) in option exercise and milestone payments Ono to fund Equillium’s continued research and development of itolizumab during the exercise period … black bart wells fargoWeb24 feb. 2024 · SAN DIEGO, Feb. 24, 2024 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated … black bar \u0026 grill the starWeb24 jan. 2024 · Top Investor Rating. Top Trading Rating. Top Consensus. Low valuations. My Screeners. All my stocks. Watchlists. Virtual Portfolios. Tools ... Exhibit No. Description 2.1 Plan of Dissolution of Metacrine, Inc. 10.1 Separation Agreement and General Release of All Claims, dated as of January 24, 2024, by and between Metacrine, Inc ... black barware setWeb14 nov. 2024 · Investor Overview - Metacrine, Inc. Investor Overview Corporate Profile We are a clinical-stage biopharmaceutical company pioneering differentiated therapies for … Investor Relations. Investor Relations. Overview; News Releases; Events & … Investor Relations. Investor Relations. Overview; News Releases; Events & … Metacrine is traded on the NASDAQ Global Market under the ticker symbol MTCR, … The Investor Relations website contains information about Metacrine, Inc.'s … gainsborough pie and mash shop sudbury